Type 2 Diabetes

Paper Summary:

This paper explores the current treatments available for patients suffering from type 2 Diabetes. Addressed here are Glipizide, Sulfonylurea, and Avandia, belonging to the thiazolidinediones. The analysis considers the patient's medical history and physical exam findings for evaluation of potential side effects, aggravation, and overall safety of the drug options.

From the Paper:

"In monotherapy considerations, there are occasions when Avandia may be more optimal than the primarily recommended Glipizide, and instances when a drug combination plan utilizing both may be warranted. Thus, both the patient and drug characteristics must be evaluated relative to each other to determine the proper course of therapy. Diabetes mellitus is a complex group of syndromes applied to disturbances in the oxidation and utilization of glucose. This occurs secondary to a malfunction of the beta cells of the pancreas, which are responsible for the production of insulin. Insulin is involved in the metabolism of carbohydrates, fats, and proteins. Diabetes mellitus can be classified as type 1 (juvenile) or type 2 (adult onset), the latter of which is discussed here. In type 2 diabetes a metabolic abnormality exists, characterizing this syndrome with insulin deficiency, insulin resistance, and increased hepatic glucose output."

More papers on Type 2 Diabetes:

• Analytical Essay # 142841 : "Prevention and Control of Type 2 Diabetes"
• Article Review # 127363 : "Cinnamon and Type 2 Diabetes"
• Analytical Essay # 126153 : "Increasing Rates of Type 2 Diabetes"
• Descriptive Essay # 143323 : "Type 2 Diabetes"

APA Citation:

MLA Citation: